India Updates Medical Device Rules, Adds EU to Regulatory Waiver List
India's revised Medical Devices Rules eliminate extra licensing for outsourced sterilization and recognize the EU for clinical investigation waivers.
The Indian government has revised its Medical Devices Rules, 2017, streamlining processes for manufacturers and expanding regulatory recognition to include the European Union. The Union Health Ministry announced these changes, which aim to reduce administrative burdens and expedite access to advanced medical technologies.
Streamlined Sterilization Licensing
Under the amended rules, manufacturers outsourcing sterilization of medical devices to facilities with valid licenses will no longer need a separate loan license for this activity. This change is designed to reduce duplication and lower compliance costs for companies that lack in-house sterilization capabilities. The ministry stated that this move will cut down on administrative burdens and associated timelines.
Additionally, a six-month transition period will allow manufacturers to adjust to new labeling requirements. This grace period is intended to provide adequate time for companies to update their packaging and labeling systems in compliance with the new regulations.
EU Added to Waiver List
The ministry also amended Rule 63 of the Medical Devices Rules, 2017, to include the European Union in the list of recognized stringent regulatory jurisdictions. This means that medical devices approved in the EU will be eligible for waivers from clinical investigation requirements in India, provided they do not have a predicate device. Previously, this list included the United States, United Kingdom, Australia, Canada, and Japan.
With the inclusion of the EU, devices approved in these regions can potentially reach Indian markets more quickly, facilitating faster patient access to innovative technologies. This regulatory adjustment coincides with the India-EU Free Trade Agreement (FTA) signed earlier this year, which includes significant tariff reductions on European medical devices.
Impact on Import Dependency
India's high dependency on imported medical devices, with 80-85% of its requirements met through imports, underscores the importance of these regulatory changes. In the fiscal year 2026, medical device imports surged by 17% year-on-year to approximately Rs 89,000 crore, driven largely by demand for high-risk, technology-intensive products.
The FTA and the inclusion of the EU in the waiver list are expected to ease compliance burdens for European multinationals operating in India. This could lead to a more dynamic market environment, potentially reducing costs and increasing the availability of advanced medical devices in the country.
These regulatory updates reflect India's ongoing efforts to align its medical device sector with global standards, aiming to foster innovation and improve healthcare outcomes for its population.